Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dylan M Marchione

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Genes & Development|February 9, 2026
The conserved N-terminal SANT1-binding domain (SBD) of EZH2 regulates PRC2 activityAgata L Patriotis, Douglas W Barrows, Yadira Soto-Feliciano, et al.
Neuron|September 4, 2021
Chromatin-mediated alternative splicing regulates cocaine-reward behaviorSong-Jun Xu, Sonia I Lombroso, Delaney K Fischer, et al.
Nature Communications|October 27, 2017
Characterization of histone acylations links chromatin modifications with metabolismJohayra Simithy, Simone Sidoli, Zuo-Fei Yuan, et al.
Blood Advances|July 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AMLPau Montesinos, Dylan M Marchione, Christian Récher, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular TumorsDong-Min Yu, Eunice Lee, Gabriel J Starrett, et al.
Blood Neoplasia|January 23, 2026
Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitorsAlex C H Liu, Severine Cathelin, Dhanoop Manikoth Ayyathan, et al.
Blood Advances|April 19, 2024
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndromeCourtney D DiNardo, Gail J Roboz, Justin M Watts, et al.
Nature Genetics|January 10, 2017
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomasSimon Papillon-Cavanagh, Chao Lu, Tenzin Gayden, et al.
Nature|September 6, 2019
The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscapeDaniel N Weinberg, Simon Papillon-Cavanagh, Haifen Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid LeukemiaAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Genes & Development|February 9, 2026
The conserved N-terminal SANT1-binding domain (SBD) of EZH2 regulates PRC2 activityAgata L Patriotis, Douglas W Barrows, Yadira Soto-Feliciano, et al.
Neuron|September 4, 2021
Chromatin-mediated alternative splicing regulates cocaine-reward behaviorSong-Jun Xu, Sonia I Lombroso, Delaney K Fischer, et al.
Nature Communications|October 27, 2017
Characterization of histone acylations links chromatin modifications with metabolismJohayra Simithy, Simone Sidoli, Zuo-Fei Yuan, et al.
Blood Advances|July 24, 2025
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AMLPau Montesinos, Dylan M Marchione, Christian Récher, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Subclonal IDH1/2 Mutations as a Targetable Vulnerability in Vascular TumorsDong-Min Yu, Eunice Lee, Gabriel J Starrett, et al.
Blood Neoplasia|January 23, 2026
Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitorsAlex C H Liu, Severine Cathelin, Dhanoop Manikoth Ayyathan, et al.
Blood Advances|April 19, 2024
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndromeCourtney D DiNardo, Gail J Roboz, Justin M Watts, et al.
Nature Genetics|January 10, 2017
Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomasSimon Papillon-Cavanagh, Chao Lu, Tenzin Gayden, et al.
Nature|September 6, 2019
The histone mark H3K36me2 recruits DNMT3A and shapes the intergenic DNA methylation landscapeDaniel N Weinberg, Simon Papillon-Cavanagh, Haifen Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid LeukemiaAmir T Fathi, Haesook T Kim, Robert J Soiffer, et al.
Pageof 3